SynthesisAesthetic plastic surgery2026
Efficacy and Safety of Er:Glass versus CO
Synthesis in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Comparative efficacy and safety of fractional carbon dioxide and erbium-based fractional lasers for atrophic acne scars: A systematic review and meta-analysis.Lasers in medical science · 2026Pooled it
- Laser treatment of acne scars: a bibliometric analysis and descriptive summary of clinical evidence directions over the past 20 years.Frontiers in medicine · 2026Pooled it
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFractional laser therapy is a cornerstone for atrophic acne scar treatment. While both ablative fractional CO
methodsA systematic literature search was performed in PubMed, Web of Science, and Cochrane Library up to March 5, 2025. Prospective randomized trials directly comparing Er:Glass and CO
resultsFour studies (98 participants) were included. Pooled analysis showed no significant difference in effective rate (OR = 0.43, 95% CI 0.03-5.98) or patient satisfaction rate (OR = 0.70, 95% CI 0.08-6.25) between lasers. PIH rates were similar (OR = 0.50, 95% CI 0.17-1.45). Er:Glass was associated with significantly less pain (MD = -1.70, 95% CI -2.13 to -1.28), shorter duration of crusting (MD = -3.53, 95% CI -4.55 to -2.52), and duration of erythema (MD = -3.16, 95% CI -3.58 to -2.74).
conclusionEr:Glass and CO LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 ."
Indexed as
Identifiers
41364211What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.